
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 8.540 | 8.540 | 0.000 |
Shares | 91.290 | 91.290 | 0.000 |
Other | 0.170 | 0.170 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.851 | 25.621 |
Price to Book | 2.688 | 2.911 |
Price to Sales | 1.865 | 3.839 |
Price to Cash Flow | 15.821 | 17.269 |
Dividend Yield | 2.948 | 1.870 |
5 Years Earnings Growth | 5.114 | 5.563 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.130 | 95.762 |
Consumer Cyclical | 0.870 | 0.847 |
Number of long holdings: 39
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Humanwell Healthcare | CNE000000QW6 | 9.57 | 20.24 | -1.08% | |
Jiangsu Hengrui | CNE0000014W7 | 8.80 | 50.27 | -1.68% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 7.72 | 217.01 | +1.07% | |
WuXi AppTec | CNE1000031K4 | 7.60 | 57.36 | +1.67% | |
Cr Sanjiu A | CNE0000011K8 | 4.63 | 42.87 | -2.23% | |
Nhwa Pharma A | CNE100000CG8 | 4.41 | 22.55 | -1.01% | |
Jointown Pharm | CNE100000W45 | 3.33 | 4.94 | +2.07% | |
Hangzhou Tigermed Consulting | CNE100001KV8 | 3.12 | 45.05 | -0.97% | |
Yunnan Baiyao A | CNE0000008X7 | 2.82 | 57.90 | -0.82% | |
Pacific Shuanglin Bio pharmacy | CNE000000F14 | 2.82 | 21.64 | -2.70% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Morgan Stanley Huaxin Multiple Fact | 583.16M | 2.48 | -1.54 | 2.16 | ||
MS Huaxin Resource Selected Mixed | 417.95M | 2.21 | -10.65 | 0.51 | ||
MS Huaxin Aggressive Growth Equity | 346.35M | 4.07 | -4.61 | 2.81 | ||
Huaxin Leading Advanced Stock | 316.65M | 6.54 | -2.76 | 5.89 | ||
Huaxin Excellent Growth Stock | 260.61M | 0.98 | -11.90 | 2.46 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review